Introduction
Knowledge regarding the modest individual contributions of common genetic variants to complex diseases is increasing [1, 2] .
Although not yet used clinically, several direct-to-consumer genetic testing companies have marketed personal genetic tests regarding disease risk, often suggesting the results will empower individuals to make risk-reducing lifestyle changes. These direct-to-consumer genetic tests have also often been offered without the involvement of health professionals [3] . A number of direct-to-consumer genetic testing products include genetic information about smoking-related diseases such as lung cancer. In surveys, consumers in general seem interested in receiving personal genetic information based on low-penetrance DNA variants [4] , and smokers specifically seem interested in genetic information about smoking-related diseases such as lung cancer [5] . One study found high levels of interest in genetic testing for smoking-related diseases specifically among young college-age smokers [6] . On the one hand, this interest could be a good thing. Young smokers, compared with older smokers, may particularly benefit from genetic risk information because of the greater potential of early intervention to reduce future disease risk. On the other hand, smokers Studies examining downstream behavioral effects of personal genetic risk information have tended to focus on smoking cessation and lung cancer risk [12] [13] [14] [15] [16] , several testing for GSTM1 [14] [15] [16] . The GSTM1 gene is absent in ∼ 50% of the population, and estimates suggest people homozygous for null allelic state ( GSTM1 -null) have a ∼ 17% increased risk for lung cancer (OR = 1.17; 95% CI = 1.07-1.27) [17] . As with commercial genetic testing, however, researchers know little about how smokers in these early studies interpreted the baseline information they received regarding the risk conferred by the GSTM1 adverse genotype.
Our overarching aim in the present study was, therefore, to assess how young smokers would interpret the risk associated with a common lung cancer-associated genetic variant, GSTM1-null, and to examine whether interest in testing was associated with perceived magnitude of risk conferred by the variant. We sampled college-age smokers recruited in a university setting because this group was the target audience for a subsequent trial of lung cancer risk genetic testing due to their higher literacy and lower motivation to quit smoking relative to other smokers [18] . Our study addressed 4 questions:
(1) How do young smokers interpret the risk associated with a common lung cancer-associated gene variant of low penetrance?
(2) Do they consider personal genetic information for lung cancer susceptibility to be personally relevant and are they interested in genetic testing for lung cancer susceptibility?
(3) Do they evaluate the information as credible, trustworthy, useful, and nondirective? (4) What factors predict interest in genetic testing for lung cancer risk among these young smokers?
We predicted (a) that this sample of young smokers would interpret the gene variant as only influencing lung cancer risk by a small amount and explored the hypothesis that they would (b), therefore, consider genetic testing for lung cancer susceptibility to be irrelevant and would express little interest in undergoing genetic testing for the variant overall. We hypothesized that the information would (c) be perceived as credible, trustworthy, useful, and nondirective, and that (d) the perceived magnitude of risk conferred by the genotype would correlate positively with interest in genetic testing. We also hypothesized that worry about lung cancer and motivation to quit smoking would correlate positively with interest in testing, based on previous research [19] .
Methods

Recruitment and Procedure
As described elsewhere [20, 21] , participants were smokers aged 18-21 years who attended the University of Florida. The inclusion criteria were being a student at the University of Florida, aged 17-22 years, having smoked at least 1 cigarette in the prior week and at least 50 cigarettes in their lifetime. We used active and passive recruitment methods. Potential participants were approached on campus and via advertisements that indicated they would receive USD 40 for participation. Interested individuals received a web link where they completed a brief screener at home (n = 409). Eligible smokers who consented completed a baseline online survey (n = 182). Following completion, they were contacted and invited to attend another session in the psychology laboratory (n = 128). At the laboratory, participants read an online brochure adapted from previous research [14, 15] describing GSTM1 genetic testing for lung cancer susceptibility. In order to simplify the risk communication message, we rounded the GSTM1 -null 1.17 OR associated with lung cancer risk up to 1.2 (i.e. we rounded the estimated 17% relative risk up to 20%). In addition to informing participants that the risk variant was associated with a 20% increased relative risk of lung cancer, we also provided the absolute risk estimates of about 9% lifetime risk for GSTM1 present and about 11% lifetime risk for GSTM1 missing. Figure 1 shows one of the brochure pages presenting one of the icon arrays depicting risk [21] for more detail regarding the icon arrays used in this study. For the complete brochure, see online supplementary material (www.karger.com/doi/10.1159/000356708). Afterwards, participants completed another questionnaire online in the laboratory. Most participants completed the laboratory session within 3 weeks of the baseline online survey. The study was approved by the Institutional Review Boards at the University of Florida and Duke University Medical Center.
Measures
Demographics
We collected participants' age, gender and race/ethnicity.
Family History of Lung Cancer
We assessed family history of lung cancer with the item: 'Please check which relatives you have that have had lung cancer'. Participants could then check one or more of 24 options, including: biological relatives such as 'brother', 'sister', 'son', 'daughter', 'father', 'mother', 'cousin (female)', 'cousin (male)', 'grandfather', and 'grandmother'; nonbiological relatives including 'husband', 'wife', 'brother-in-law', and 'sister-in-law'; and other relationships such as 'friend' and 'other (please specify)'. We summed all of the biological relatives and categorized participants according to whether they had zero (low family history-based risk), 1 (moderate family history-based risk), or 2 or more (high family history-based risk) biological relatives with lung cancer.
Smoking Characteristics
Motivation to quit smoking (1 = not at all strong, 7 = extremely strong) and worry about lung cancer (1 = never, 7 = more than once a day) were assessed using single items.
Perceived Risk of Lung Cancer
We measured perceived risk of lung cancer (unrelated to GSTM1 ) in 2 ways. First, we assessed 'perceived absolute risk of lung cancer' as follows: 'What do you think is your chance of getting lung cancer from your smoking if you don't quit?' (1 = no chance, 7 = certain to happen). Second, we assessed 'perceived relative risk of lung cancer' as follows: 'Compared to other college smokers your age and sex, what do you think is your chance of getting lung cancer from your smoking if you don't quit?' (1 = much below average, 5 = much above average).
Interpretation of Lung Cancer Risk Conferred by GSTM1
Interpretation of lung cancer risk associated with GSTM1 was assessed on 2 dimensions. The first, 'increases-decreases' dimension assessed interpretation of absolute risk for a smoker generally using a 7-point scale: 'Having/missing the GSTM1 enzyme… 1 = decreases a smoker's expected risk of getting lung cancer by a lot, 2 = decreases a smoker's expected risk of getting lung cancer by a moderate amount, 3 = decreases a smoker's expected risk of getting lung cancer by a little, 4 = does not affect a smoker's expected risk of getting lung cancer, 5 = increases a smoker's risk of getting lung cancer by a little, 6 = increases a smoker's expected risk of getting lung cancer by a moderate amount, 7 = increases a smoker's expected risk of getting lung cancer by a lot. ' The second, 'relative-to-average' approach assessed interpretation of personal risk relative to other smokers using a 5-point scale: 'Overall, if you have/are missing the GSTM1 enzyme, what is your risk of getting lung cancer? 1 = much lower than average, 2 = slightly lower than average, 3 = same average risk as others, 4 = slightly higher than average, 5 = much higher than average.'
Assessment of the Information Brochure
We assessed whether participants perceived the information as credible, trustworthy, useful, and understandable with 4 items: 'In your opinion, how credible , that is believable, is the information presented to you about genetic testing and lung cancer susceptibility? (1 = not at all credible, 7 = completely credible)'; 'In your opinion, how trustworthy is the information presented to you about genetic testing and lung cancer susceptibility? (1 = not at all trustworthy, 7 = completely trustworthy)'; 'How useful was the information presented to you about genetic testing and lung cancer susceptibility? (1 = not at all useful, 7 = extremely useful)'; 'How understandable was the information presented to you about genetic testing and lung cancer susceptibility? (1 = not at all understandable, 7 = completely understandable)'.
We assessed the perceived adequacy of the information for decision making with an item that read: 'Do you feel the information was adequate for people to make decision about genetic testing for lung cancer susceptibility? (yes, somewhat, no)'. We assessed the perceived directiveness of the information with an item that read: 'Did you find that the information you reviewed told you whether or not you should be tested? (yes, somewhat, no)'. These items were analyzed separately.
Perceived Personal Relevance
We assessed perceived personal relevance with 6 items from the 10-item Personal Involvement Inventory [22] . All items loaded on a single factor with eigenvalues >0.4, Cronbach's alpha = 0.87.
Interest in Testing
We assessed interest in testing for GSTM1 after reading the brochure with a single item (1 = not at all interested, 7 = extremely interested).
Statistical Analyses
We analyzed demographic and smoking characteristics, understandability, credibility, perceived usefulness, personal relevance, and interest in genetic testing using frequencies, means and SDs. We explored bivariate associations between interest in genetic testing and other variables using Pearson correlations and simultaneous regression analysis. Analyses were conducted using SPSS v. 19 .0. is, what GSTM1 is and how GSTM1 may be associated with lung cancer risk as well as the risks, benefits and limitations of GSTM1 genetic testing for lung cancer risk. As the figure illustrates, here participants were informed that absolute risk of developing lung cancer if missing GSTM1 was estimated to be about 11 out of 100 (or 11%), and that absolute risk of developing lung cancer if GSTM1 is present was estimated to be about 9 out of 100 (or 9%).
Results
Demographic and Smoking-Related Characteristics at Baseline
Descriptive statistics for the participants are published elsewhere [20, 21] ; table 1 shows the demographic and additional smoking-related characteristics.
Interpretation of Disease Risk Conferred by the Common Gene Variant
In regards to our first research question, when interpretation was assessed using the 5-point 'relative-to-average' measure, 89% of the participants agreed their personal lung cancer risk would be 'slightly higher than average' if they were GSTM1-missing; 78% agreed their lung cancer risk would be 'slightly lower than average' if GSTM1-present ( fig. 2 ) . Mean response for the latter item (mean = 2.2, SD = 0.52) was significantly lower than the scale midpoint (95% CI = -0.90 to -0.71, t = 17.57; p < 0.001), whereas mean response for the former item (mean = 4.0, SD = 0.47) was significantly higher than the scale midpoint (95% CI = 0.90-1.07, t = 23.73; p < 0.001).
When assessed using the 7-point 'increases-decreases' measure, 59% of the participants agreed GSTM1 -missing 'increases risk a little', and 59% agreed GSTM1 -present 'decreases risk a little' ( fig. 3 ). As figure 3 shows, a third (34%) of participants agreed GSTM1 -missing 'increases risk a moderate amount'. Mean response to the first item (mean = 5.3, SD = 0.81) was significantly higher than the scale midpoint (95% CI = 1.19-1.47, t = 18.45; p < 0.001). Mean response to the second item (mean = 2.6, SD = 0.69) was significantly lower than the scale midpoint (95% CI = -1.37 to -1.13, t = 20.58; p < 0.001).
Although responses to the 4 interpretation items differed significantly from the scale midpoint, the pattern of responses displayed in figures 2 and 3 suggests that most participants interpreted that the GSTM1 -null gene variant influenced the disease risk only a small amount, thus, supporting hypothesis 1.
Perceived Personal Relevance of the Information and Interest in Testing
In regards to our second research question, participants on average perceived the information to be personally relevant (mean = 5.8, SD = 1.1) and were interested in genetic testing (mean = 5.2, SD = 1.66, range 1-7). Both means were greater than the scale midpoint (p < 0.0001), providing no evidence to support hypothesis 2.
Assessment of the Information Brochure
In regards to our third question, participants on average indicated they perceived the genetic information to be credible (mean = 6.0, SD = 0.9), trustworthy (mean = 5.7, SD = 1.2), useful (mean = 5.7, SD = 1.2), and understandable (mean = 6.6, SD = 0.7); all means were greater than the scale midpoint (all p < 0.0001). These findings support hypothesis 3.
Sixty-seven percent of participants thought the information was adequate for decision making and another 30% thought it was somewhat adequate. Believing the information was adequate for decision making correlated with believing the information was credible (r = 0.35, p < 0.001), trustworthy (r = 0.34, p < 0.001), useful (r = 0.24, p < 0.006), understandable (r = 0.27, p < 0.003), and personally relevant (r = 0.30, p < 0.001), and with interest in genetic testing (r = 0.19, p < 0.05).
Of note, participants tended to perceive that the information in the brochure was telling them whether they 3.9 ± 1.72 (1 -7) Worry about lung cancer (1 = never, 7 = more than once a day)
2.4 ± 1.17 (1 -6) Perceived absolute risk of lung cancer (1 = no chance, 7 = certain to happen) 4.4 ± 1.24 (1 -7) Perceived comparative risk of lung cancer (1 = much below average, 5 = much above average) 2.9 ± 0.90 (1 -5) a Due to incomplete data from one participant, the numbers do not sum to 100%. b Assessed after brochure was presented (all other measures were assessed before).
Figures are numbers with percentages or mean ± SD with ranges in parentheses.
should have genetic testing: 37% responded 'yes' the information told them whether to be tested, 43% said 'somewhat', and 20% 'no'.
Factors Associated with Interest in Genetic Testing
We found no support for hypothesis 4. Interest in genetic testing was not associated with interpretations of risk conferred by the gene variant, but was associated with perceived relevance and usefulness of the information, and with worry ( table 2 ). Worry about lung cancer correlated with having a family history of lung cancer and perceived relevance of the information. Because of the shared variance between the various predictors of interest in getting a genetic test, we entered all variables significant at p < 0.05 in table 2 as predictors of interest in getting a genetic test in a simultaneous regression analysis. Only one variable -relevance -emerged as a significant predictor of interest, b = 0.14, SE = 0.02, t = 6.67, p < 0.0001. Further probing revealed that relevance accounted for 31% of the variance in participants' interest in getting a genetic test. The other variables collectively accounted for only 1.5% additional variance. How much does missing the GSTM1 enzyme influence a smoker's expected risk of lung cancer? Fig. 3 . Interpretation of lung cancer risk conferred by GSTM1 to general smoker on 7-point scale. This figure illustrates that 59% of participants interpreted the information they received to mean that having GSTM1 'decreases risk a little' and that 29% interpreted it to mean that having GSTM1 present 'decreases risk a moderate amount'. It also illustrates that 59% of participants interpreted the information to mean that missing GSTM1 'increases risk a little', and that 34% interpreted it to mean that missing GSTM1 'increases risk a moderate amount'.
Discussion
In this study, we examined young smokers' responses to an information brochure that described in detail the lung cancer risk estimated to be associated with a common genetic variant. The majority of participants appeared to interpret the lung cancer risk conferred by the GSTM1 variant as 'small' on one measure, but over a third interpreted the risk conferred by the variant as 'moderate' on another. Participants perceived the information to be credible, trustworthy, useful, and understandable, although a third perceived it to be directive. Interest in being testing for GSTM1 was quite high and not associated with perceptions of lung cancer risk conferred by the gene variant.
The finding that a substantial proportion of participants interpreted an increase of about 20% in relative terms, and from about 9 to 11% lifetime risk in absolute terms, as a 'moderate' increase in risk on one of the measures of risk interpretation, was something of a surprise and could be a reflection of poor understanding of risk information among the smokers in this study. Even healthcare providers have limited understanding of genetics [2, 9] and low probabilities [10] . An alternative explanation is that the participants focused on the gist of the information presented in the brochure -that having the gene was 'good', whereas not having the gene was 'bad' -and that under these circumstances interpreting the risk as 'moderate' is not in fact surprising or unreasonable. This latter interpretation challenges current notions in the genomics community that ORs in the realms of 1.2, or relative risks of about 20%, are too small to have meaning for individuals. Either way, the finding highlights the need for further work understanding how people interpret small increases or decreases in genetic risk and how to effectively communicate such risk information.
Nondirectiveness is a guiding principle for genetic counseling [23] , and it is, therefore, arguably problematic that a substantial minority of participants felt the information presented in the brochure was directive. While important in promoting autonomy in genetic counseling contexts such as reproductive decision making, it has been argued that nondirectiveness is of less importance in emerging areas of genetic counseling such as those that focus on lifestyle behavior changes [23] , and so being directive in the present context of nicotine smoking could be defensible. Even here, however, evidence suggests that being directive could be undesirable because it could elicit 'psychological reactance' [24] . The theory of psychological reactance posits that young smokers could respond to efforts to 'tell them what to do' by showing the opposite behavior in an attempt to reassert their freedom [24] . As genomics is increasingly considered in the context of preventive lifestyle behavior change interventions, it will be important to consider further the extent to which directiveness or nondirectiveness is seen as a guiding principle for genetic risk communications. Our findings have implications for how the understanding of genetic risk is assessed in future studies. Two different measures of interpretation of risk led to different outcomes -whereas the 5-point measure suggested participants 'got' that the gene variant was associated with only a 'slightly higher' than average disease risk, the 7-point measure showed more sensitivity and many participants interpreted the information to mean the variant increased risk 'by a moderate amount'. This greater sensitivity was most likely due to the larger number of response options provided, but this requires confirmation in future work.
Previous research suggests a major reason people generally are interested in personal genetic information is curiosity [4] , and we have previously demonstrated this in our sample of young smokers [20] . Our finding in the present study that there was no association between interpretation of the risk information presented and interest in testing build on this notion by suggesting interest is not fundamentally based on misunderstanding or overinterpreting the strength of disease risk conferred by the gene variant.
Limitations included that the information brochure we used to educate participants about the genetic test was text-heavy and long. It was designed for use in a subsequent trial in which young smokers were offered GSTM1 genetic testing, and so went into considerable depth about this one gene variant and disease association. However, as whole genome sequencing replaces single variant genetic tests, it will no longer be feasible to go into such depth explaining every possible result that might be returned to the individual. Researchers will need to develop new multimedia approaches to explaining potential genetic results to help individuals make informed decisions about genomic testing or sequencing in the future. Also, the fact that our sample comprised college-age smokers limits the generalizability of our findings. Finally, we presented the genetic information within the context of a research study with university students, which could have influenced the students' ratings of the credibility and trustworthiness of the information provided in the brochure.
Despite the limitations, this study is unique in that researchers have devoted little effort to developing and evaluating decision aids for young smokers or people more generally who are considering personal genetic testing or sequencing. Our findings contribute to growing evidence that smokers are interested in personal genetic risk information even when they are aware of the low utility for disease risk prediction and highlight considerations regarding how smokers interpret risk information they receive in educational materials. The findings are relevant to interventionists in clinical practice or public health because they suggest that even when the risk associated with genetic variation appears to be low in absolute terms, a considerable number of smokers may nonetheless interpret their risk feedback as meaningful information. Going forward, more work is needed to develop effective decision support tools to help smokers and nonsmokers make informed decisions in the context of genetic testing or sequencing that involves variants of low penetrance.
